Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Fda Inspections
  6. /
  7. Lucile Salter Packard Children's Hospital Stanford Medicine Fertility and Reproductive Health
FDA Inspection
•Lucile Salter Packard Children's Hospital Stanford Medicine Fertility and Reproductive Health•April 27, 2023

Lucile Salter Packard Children's Hospital Stanford Medicine Fertility and Reproductive Health – FDA Inspection, Apr 27, 2023

Record Details

This FDA Inspection record concerns Lucile Salter Packard Children's Hospital Stanford Medicine Fertility and Reproductive Health, with an inspection on April 27, 2023, issued by the Center for Biologics Evaluation and Research, covering biologics.

Company
Lucile Salter Packard Children's Hospital Stanford Medicine Fertility and Reproductive Health
Inspection Date
April 27, 2023
Product Type
Biologics
Office
Center for Biologics Evaluation and Research
Person
  • Shelley H. Beausoleil (Issuing Officer)
View Company Profile

ID · 89340b69-eebb-4bc8-ab62-a623fcb46ae3

Inspection Facts

Voluntary Action Indicated (VAI)

Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.

Inspection number
1203818
FDA center
Biologics
Project area
Human Cellular, Tissue, and Gene Therapies
Outcome
Form 483 issued

FDA Citations

1
  1. 21 CFR 1271.80(c)Manufacturer instructions not followed

Full citation text and observation details available on the Dashboard.

Other FDA inspections of Lucile Salter Packard Children's Hospital Stanford Medicine Fertility and Reproductive Health

5
DateClassificationOfficeProject area
April 18, 2025NAICenter for Biologics Evaluation and ResearchHuman Cellular, Tissue, and Gene Therapies
February 28, 2017NAICenter for Biologics Evaluation and ResearchHuman Cellular, Tissue, and Gene Therapies
January 7, 2014VAICenter for Biologics Evaluation and ResearchHuman Cellular, Tissue, and Gene Therapies
December 19, 2012NAICenter for Biologics Evaluation and ResearchHuman Cellular, Tissue, and Gene Therapies
September 22, 2010NAICenter for Biologics Evaluation and ResearchHuman Cellular, Tissue, and Gene Therapies
Other documents for Lucile Salter Packard Children's Hospital Stanford Medicine Fertility and Reproductive Health
  • FDA Inspection 1267717 - 2025-04-18
  • FDA Inspection 1002842 - 2017-02-28
  • FDA Inspection 860761 - 2014-01-07
  • FDA Inspection 811732 - 2012-12-19
  • FDA Inspection 681080 - 2010-09-22

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Lucile Salter Packard Children's Hospital Stanford Medicine Fertility and Reproductive Health
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.